Asset Details
Do you wish to reserve the book?
Enhancing the diagnostic yield of monogenic diabetes in unresolved cases with early-onset hyperglycemia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Enhancing the diagnostic yield of monogenic diabetes in unresolved cases with early-onset hyperglycemia
Do you wish to request the book?
Enhancing the diagnostic yield of monogenic diabetes in unresolved cases with early-onset hyperglycemia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Enhancing the diagnostic yield of monogenic diabetes in unresolved cases with early-onset hyperglycemia
2025
Overview
Background
To improve the precision of molecular diagnosis by means of a comprehensive bidirectional phenotypic and genotypic reanalysis in cases of unresolved monogenic diabetes previously investigated using a targeted next-generation sequencing (tNGS) panel.
Methods
Molecular and clinical data from 128 unresolved cases referred between 2011 and 2019 were analyzed. These included 92 cases of suspected maturity-onset diabetes of the young (MODY), 12 of neonatal diabetes, 16 of familial partial lipodystrophy (FPLD), 7 of mitochondrial diabetes, and 1 of Wolfram syndrome. All cases were initially investigated using a tNGS panel consisting of 51 nuclear genes and the complete mitochondrial genome.
Results
This extensive reanalysis process increases molecular diagnosis from 9 to 22%. Phenotypic reevaluation, entailing in-depth phenotyping, is instrumental in excluding 62 atypical cases (48.4%). Genotypic reanalysis identifies 5 previously overlooked molecular defects: two mutations in regulatory regions (one in the
HNF1A
promoter and another in the
PTF1A
enhancer); one in the
MTTK
mitochondrial gene; one in the
MFN2
gene; and one in the
GCK
gene.
Conclusions
Our findings indicate that a combined approach of genotypic and, mainly, phenotypic reanalysis is an effective strategy for improving the accuracy of molecular diagnosis in individuals with suspected monogenic diabetes.
Plain language summary
Some people develop diabetes early in life due to inherited genetic conditions. However, identifying the exact cause can be difficult, and many people remain without a diagnosis after initial testing. In this study, researchers revisited the medical and genetic data of 128 individuals who were previously suspected to have a genetic form of diabetes but remained undiagnosed. By combining updated genetic tools with detailed clinical review, they were able to provide new diagnoses for some and rule out inherited diabetes in others. Because knowledge in genetics evolves rapidly, this study highlights the importance of reanalyzing past test results over time. Doing so can lead to more accurate diagnoses and better care for individuals and families affected by early-onset diabetes.
Franco et al. perform a combined phenotypic and genotypic reanalysis of unresolved 128 monogenic diabetes cases. Their approach increases diagnostic yield and highlights the key role of deep phenotyping in previously overlooked cases, and provides a diagnosis for suspected cases.
Publisher
Nature Publishing Group UK,Springer Nature B.V,Nature Portfolio
